Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 6
2002 5
2003 6
2004 10
2005 4
2006 8
2007 6
2008 8
2009 4
2010 1
2011 2
2012 7
2013 8
2014 5
2015 10
2016 4
2017 8
2018 3
2019 3
2021 4
2022 4
2023 4
2024 5
2025 5
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

117 results

Results by year

Filters applied: . Clear all
Page 1
Anamorelin for cancer cachexia.
Nishie K, Sato S, Hanaoka M. Nishie K, et al. Drugs Today (Barc). 2022 Mar;58(3):97-104. doi: 10.1358/dot.2022.58.3.3381585. Drugs Today (Barc). 2022. PMID: 35274629 Review.
It is associated with functional impairment, changes in body composition and nutritional disorders. Ghrelin receptors are involved in the release of growth hormone (GH) in the pituitary gland and increase appetite via the hypothalamus. The secretion of …
It is associated with functional impairment, changes in body composition and nutritional disorders. Ghrelin receptors are invo …
Ghrelin and growth hormone secretagogues, physiological and pharmacological aspect.
Cordido F, Isidro ML, Nemiña R, Sangiao-Alvarellos S. Cordido F, et al. Curr Drug Discov Technol. 2009 Mar;6(1):34-42. doi: 10.2174/157016309787581048. Curr Drug Discov Technol. 2009. PMID: 19275540 Free article. Review.
The first "growth hormone secretagogues" (GHSs) were discovered by Bowers et al. in 1977. In 1996 the GHSs receptor (GHS-R 1a) was cloned. The endogenous ligand for this receptor, ghrelin, was not identified until 1999. Synthetic molecules terme …
The first "growth hormone secretagogues" (GHSs) were discovered by Bowers et al. in 1977. In 1996 the GHSs receptor (GH …
Capromorelin: a ghrelin receptor agonist and novel therapy for stimulation of appetite in dogs.
Rhodes L, Zollers B, Wofford JA, Heinen E. Rhodes L, et al. Vet Med Sci. 2017 Nov 6;4(1):3-16. doi: 10.1002/vms3.83. eCollection 2018 Feb. Vet Med Sci. 2017. PMID: 29468076 Free PMC article. Review.
Ghrelin causes a release of growth hormone (GH) through binding to GHS-R1a in the hypothalamus and pituitary gland. A class of compounds known as growth hormone secretagogues, or ghrelin receptor agonists, were developed for
Ghrelin causes a release of growth hormone (GH) through binding to GHS-R1a in the hypothalamus and pituitary gland. A c
The growth hormone secretagogue receptor.
Cruz CR, Smith RG. Cruz CR, et al. Vitam Horm. 2008;77:47-88. doi: 10.1016/S0083-6729(06)77004-2. Vitam Horm. 2008. PMID: 17983853 Review.
The neuroendocrine hormone ghrelin, a recently discovered acylated peptide with numerous activities in various organ systems, exerts most of its known effects on the body through a highly conserved G-protein-coupled receptor, the growth hormone
The neuroendocrine hormone ghrelin, a recently discovered acylated peptide with numerous activities in various organ systems, …
Growth hormone secretagogue (ghrelin-) receptors--a complex drug target for the regulation of body weight.
Nogueiras R, Perez-Tilve D, Wortley KE, Tschöp M. Nogueiras R, et al. CNS Neurol Disord Drug Targets. 2006 Jun;5(3):335-43. doi: 10.2174/187152706777452227. CNS Neurol Disord Drug Targets. 2006. PMID: 16787234 Review.
The growth hormone secretagogue receptor (GHS-R) is expressed in several tissues and seems to mediate the different actions of the synthetic growth hormone secretagogues (GHS) and the endogenous ligand of this receptor, ghrelin. .. …
The growth hormone secretagogue receptor (GHS-R) is expressed in several tissues and seems to mediate the different act …
Toward a consensus nomenclature for ghrelin, its non-acylated form, liver expressed antimicrobial peptide 2 and growth hormone secretagogue receptor.
Perelló M, Dickson SL, Zigman JM, Leggio L; Ghrelin Nomenclature Consensus Group. Perelló M, et al. J Neuroendocrinol. 2023 Jan;35(1):e13224. doi: 10.1111/jne.13224. Epub 2022 Dec 29. J Neuroendocrinol. 2023. PMID: 36580314 Free PMC article. Review.
The stomach-derived octanoylated peptide ghrelin was discovered in 1999 and recognized as an endogenous agonist of the growth hormone secretagogue receptor (GHSR). Subsequently, ghrelin has been shown to play key roles in controlling not …
The stomach-derived octanoylated peptide ghrelin was discovered in 1999 and recognized as an endogenous agonist of the grow
Growth hormone secretagogue receptor family members and ligands.
Smith RG, Leonard R, Bailey AR, Palyha O, Feighner S, Tan C, Mckee KK, Pong SS, Griffin P, Howard A. Smith RG, et al. Endocrine. 2001 Feb;14(1):9-14. doi: 10.1385/ENDO:14:1:009. Endocrine. 2001. PMID: 11322507 Review.
We have previously reported the cloning and characterization of a new orphan G-protein-coupled receptor (GPC-R), the growth hormone secretagogue receptor (GHS-R), and shown that this receptor mediates the activity of the growth hormone
We have previously reported the cloning and characterization of a new orphan G-protein-coupled receptor (GPC-R), the growth
SARCOPENIA: AN ENDOCRINE DISORDER?
McKee A, Morley JE, Matsumoto AM, Vinik A. McKee A, et al. Endocr Pract. 2017 Sep;23(9):1140-1149. doi: 10.4158/EP171795.RA. Epub 2017 Jul 13. Endocr Pract. 2017. PMID: 28704095 Review.
Other causes are decreased physical activity, loss of motor neuron units, weight loss, inflammatory cytokines, reduced blood flow to muscles, very low 25(OH) vitamin D levels, and decreased growth hormone and insulin-like growth factor 1. Treatment for sarcop …
Other causes are decreased physical activity, loss of motor neuron units, weight loss, inflammatory cytokines, reduced blood flow to muscles …
Insights on discovery, efficacy, safety and clinical applications of ghrelin receptor agonist capromorelin in veterinary medicine.
Rathore M, Das N, Ghosh N, Guha R. Rathore M, et al. Vet Res Commun. 2024 Feb;48(1):1-10. doi: 10.1007/s11259-023-10184-0. Epub 2023 Jul 26. Vet Res Commun. 2024. PMID: 37493940 Review.
Growth Hormone is released from the pituitary through a specific G-protein coupled receptor (GPCR) called growth hormone secretagogue receptor 1a expressed in the hypothalamus. ...A class of compound known as ghrelin receptor
Growth Hormone is released from the pituitary through a specific G-protein coupled receptor (GPCR) called growth
Ghrelin: much more than a natural growth hormone secretagogue.
Broglio F, Arvat E, Benso A, Gottero C, Prodam F, Granata R, Papotti M, Muccioli G, Deghenghi R, Ghigo E. Broglio F, et al. Isr Med Assoc J. 2002 Aug;4(8):607-13. Isr Med Assoc J. 2002. PMID: 12183865 Free article. Review.
Ghrelin, a 28 amino acid acylated peptide predominantly produced by the stomach, displays strong growth hormone-releasing activity mediated by the hypothalamus-pituitary GH secretagogue receptors that were found to be specific for a family of synthetic
Ghrelin, a 28 amino acid acylated peptide predominantly produced by the stomach, displays strong growth hormone-releasi
117 results